New Castle, DE, United States of America

Beth M Anaclerio


Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Beth M. Anaclerio

Introduction: Beth M. Anaclerio, an accomplished inventor based in New Castle, DE, is known for her significant contributions to the pharmaceutical field. With a total of three patents to her name, she has dedicated her work to developing novel solutions that address various medical conditions.

Latest Patents: Anaclerio's latest patents showcase her innovation in drug development, particularly in the realm of integrin antagonists. One of her patents focuses on "Substituted Indoles and Their Use as Integrin Antagonists," which details novel substituted indole compounds with the potential to treat pathological conditions mediated by integrins. These conditions include tumor growth, metastasis, osteoporosis, and rheumatoid arthritis, among others. Another noteworthy patent covers "Substituted Benzofurans and Benzothiophenes," again focusing on integrin antagonists and their therapeutic applications.

Career Highlights: Throughout her career, Anaclerio has worked with prominent organizations, including Dimensional Pharmaceuticals, Inc. and 3-Dimensional Pharmaceutical, Inc. Her work in these companies has pushed the boundaries of pharmaceutical research, leading to groundbreaking innovations in drug development.

Collaborations: Anaclerio has collaborated with notable individuals in the field, such as Juan J. Marugan Sanchez and Victor J. Marder. These partnerships have contributed to her successful patent accomplishments and the advancement of her research initiatives.

Conclusion: Beth M. Anaclerio stands out as a pioneering inventor in the pharmaceutical industry. Her innovative patents focusing on integrin antagonists reflect her commitment to improving health outcomes for patients suffering from various medical conditions. Her work, supported by collaborations with esteemed colleagues, continues to inspire future advancements in drug discovery and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…